Research ArticleArticle
Use of Cryopreserved Hepatocytes as Part of an Integrated Strategy to Characterize In Vivo Clearance for Peptide-Antibody Conjugate Inhibitors of Nav1.7 in Preclinical Species
Robert S Foti, Kaustav Biswas, Jennifer Aral, Xuhai Be, Loren Berry, Yuan Cheng, Kip Conner, James R Falsey, Charles Glaus, Brad Herberich, Dean Hickman, Tayo Ikotun, Hongyan Li, Jason Long, Liyue Huang, Les P Miranda, Justin Murray, Bryan Moyer, Chawita Netirojjanakul, Thomas E Nixey, Kelvin Sham, Marcus Soto, Christopher M Tegley, Linh Tran, Bin Wu, Lin Yin and Dan A Rock
Drug Metabolism and Disposition August 6, 2019, dmd.119.087742; DOI: https://doi.org/10.1124/dmd.119.087742
Robert S Foti
1 Amgen;
Kaustav Biswas
2 Merck;
Jennifer Aral
1 Amgen;
Xuhai Be
1 Amgen;
Loren Berry
3 Takeda;
Yuan Cheng
1 Amgen;
Kip Conner
1 Amgen;
James R Falsey
1 Amgen;
Charles Glaus
3 Takeda;
Brad Herberich
1 Amgen;
Dean Hickman
1 Amgen;
Tayo Ikotun
4 Bristol-Myers Squibb;
Hongyan Li
1 Amgen;
Jason Long
1 Amgen;
Liyue Huang
5 Epizyme;
Les P Miranda
1 Amgen;
Justin Murray
1 Amgen;
Bryan Moyer
1 Amgen;
Chawita Netirojjanakul
1 Amgen;
Thomas E Nixey
3 Takeda;
Kelvin Sham
1 Amgen;
Marcus Soto
1 Amgen;
Christopher M Tegley
6 Proneurotech, Inc;
Linh Tran
1 Amgen;
Bin Wu
1 Amgen;
Lin Yin
7 Wuxi AppTec
Dan A Rock
1 Amgen;
Data Supplement
- Supplemental Table -
Surrogate Peptide Sequences and MRM Ion Transitions